Category Archives: Featured Penny Picks
Penny Stock Pick Feature XNPT XenoPort, Inc.
XenoPort, Inc. (XNPT): Nasdaq are a biopharmaceutical company focused on developing a portfolio of internally discovered product candidates that utilize the body’s natural nutrient transporter mechanisms to improve the therapeutic benefits of drugs. Our most advanced product candidate is currently being evaluated in a Phase 3 clinical program for the treatment of restless legs syndrome, [...]
Penny Stock Pick Feature CXM Cardium Therapeutics, Inc.
We have added Cardium Therapeutics, Inc. (CXM): NYSE Amex to our featured and our watch list today. As our subscribers know we just love the pharma tech plays specially the smaller ones as they could have potential for some big moves. Cardium Therapeutics, Inc. (CXM): NYSE Amex Cardium Therapeutics is focused on the acquisition and [...]
Penny Stock Pick Feature ALXA Alexza Pharmaceuticals, Inc.
We have added Alexza Pharmaceuticals, Inc. (ALXA): Nasdaq to our featured and our watch list today with the upcoming FDA meeting in October for AZ-004 Staccato loxapine, we ask you to do some research on this company. We just love the pharma tech plays specially the smaller ones as they could have potential for big [...]
ACAD featured Phase 3 play
We have added ACADIA Pharmaceuticals Inc. (ACAD): Nasdaq to our featured and our watch list today and ask you to do some research on this company. We just love the pharma tech plays specially the smaller ones as they could have potential for big moves. ACADIA Pharmaceuticals Inc. (ACAD) : Nasdaq ) Currently trading on [...]
Arena Pharmaceuticals, Inc. ARNA : Nasdaq
ARNA could start to become quite interesting play on the run up to the NDA, The FDA has notified the company of the tentative scheduling of an Endocrinologic and Metabolic Drugs Advisory Committee meeting on September 16, 2010, for the review of the lorcaserin New Drug Application. The shares are trading up pre market on [...]
RPRX featured FDA play
This could be a little gem short term and seems to be hidden FDA play, Repros Requests a lift of the clinical hold on Proellex to continue work with its drug Proellex after it was found to cause changes in the liver enzymes at higher doses with the oral drug, and they are now wanting to continue [...]